Target Gene Table
VIS IDVirusEnsembl IDGene TypeTarget GeneOncogeneTumor Suppressor GeneNCBI IDUniprot ID
TVIS30026962HIVENSG00000133019.12protein_codingCHRM3NoNo1131P20309
TVIS30026963HIVENSG00000133019.12protein_codingCHRM3NoNo1131P20309
TVIS20001445HPVENSG00000133019.12protein_codingCHRM3NoNo1131P20309
TVIS20001070HPVENSG00000133019.12protein_codingCHRM3NoNo1131P20309
TVIS20041095HPVENSG00000133019.12protein_codingCHRM3NoNo1131P20309
TVIS20038300HPVENSG00000133019.12protein_codingCHRM3NoNo1131P20309
TVIS20046168HPVENSG00000133019.12protein_codingCHRM3NoNo1131P20309
TVIS20044845HPVENSG00000133019.12protein_codingCHRM3NoNo1131P20309
TVIS20042956HPVENSG00000133019.12protein_codingCHRM3NoNo1131P20309
TVIS20065709HPVENSG00000133019.12protein_codingCHRM3NoNo1131P20309
TCGA Plot Options
Drug Information
GeneCHRM3
DrugBank IDDB00334
Drug NameOlanzapine
Target IDBE0000045
UniProt IDP20309
Regulation Typeantagonist
PubMed IDs17848919; 10227113; 25032030
CitationsNasrallah HA: Atypical antipsychotic-induced metabolic side effects: insights from receptor-binding profiles. Mol Psychiatry. 2008 Jan;13(1):27-35. Epub 2007 Sep 11.@@Bymaster FP, Nelson DL, DeLapp NW, Falcone JF, Eckols K, Truex LL, Foreman MM, Lucaites VL, Calligaro DO: Antagonism by olanzapine of dopamine D1, serotonin2, muscarinic, histamine H1 and alpha 1-adrenergic receptors in vitro. Schizophr Res. 1999 May 4;37(1):107-22.@@Brafford MV, Glode A: Olanzapine: an antiemetic option for chemotherapy-induced nausea and vomiting. J Adv Pract Oncol. 2014 Jan;5(1):24-9.
GroupsApproved; Investigational
Direct ClassificationBenzodiazepines
SMILESCN1CCN(CC1)C1=NC2=CC=CC=C2NC2=C1C=C(C)S2
Pathways
PharmGKBPA450688
ChEMBLCHEMBL715